855775-84-7Relevant academic research and scientific papers
Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia
Ko?aczkowski, Marcin,Marcinkowska, Monika,Bucki, Adam,?niecikowska, Joanna,Paw?owski, Maciej,Kazek, Grzegorz,Siwek, Agata,Jastrz?bska-Wi?sek, Magdalena,Partyka, Anna,Wasik, Anna,Weso?owska, Anna,Mierzejewski, Pawe?,Bienkowski, Przemyslaw
supporting information, p. 221 - 235 (2015/06/30)
We describe a novel class of designed multiple ligands (DMLs) combining serotonin 5-HT6 receptor (5-HT6R) antagonism with dopamine D2 receptor (D2R) partial agonism. Prototype hybrid molecules were designed usin
INDOLE DERIVATIVES FOR THE TREATMENT OF BONE DISEASES
-
Page/Page column 48, (2010/02/12)
This invention relates to a method for preventing and/or treating bone diseases which comprises administering a potentiator of TGF-beta activity such as the compound of the formula [I] or pharmaceutically acceptable salts thereof to human being or animals
